HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$2.86
Day range
$2.87 - $3.05
Year range
$0.97 - $4.00
Market cap
208.30M USD
Avg Volume
248.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.93M | 34.19% |
Net income | -7.82M | -42.07% |
Net profit margin | — | — |
Earnings per share | -0.08 | -33.33% |
EBITDA | -8.90M | -33.97% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 82.97M | -31.15% |
Total assets | 89.40M | -27.32% |
Total liabilities | 6.86M | -55.93% |
Total equity | 82.55M | — |
Shares outstanding | 68.96M | — |
Price to book | 2.36 | — |
Return on assets | -24.10% | — |
Return on capital | -25.54% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.82M | -42.07% |
Cash from operations | -6.36M | -0.44% |
Cash from investing | 12.84M | 126.59% |
Cash from financing | -54.00K | -108.28% |
Net change in cash | 6.43M | 111.91% |
Free cash flow | -3.50M | 35.48% |
About
Founded
2011
Headquarters
Website
Employees
25